Annual report
7733.TEDINET S100QZRG
Period2022-04-01 → 2023-03-31
Filed2023-06-20
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Amended by S100RV9X (2023-09-19).
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥881.9bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥750.1bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥730.5bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥755.2bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥793.9bn | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥186.6bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥146.2bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥182.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥141.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥76.8bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥86.6bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥20.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥143.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥115.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥12.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥51.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥8.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥143.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥116.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.51T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.36T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.18T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.02T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥932.0bn | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥867.1bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥846.6bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥641.2bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥511.4bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥395.5bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥640.1bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥510.2bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥394.3bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥370.7bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥441.2bn | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥169.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥205.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥302.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥217.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥162.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥114.6bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥98.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥169.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥124.1bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥133.5bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥66.9bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥58.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥71.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥118.9bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥62.4bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥60.3bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥143.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥40.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥40.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥19.5bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥82.9bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥113.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥90.22 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥10.05 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥39.37 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥5.97 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥113.08 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥90.17 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥10.04 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥39.36 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥5.96 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥510.62 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥400.75 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥306.72 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥288.39 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥323.06 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 42.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.6% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 33.3% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 36.5% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.3% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 24.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 25.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.8% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 32,844 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 31,557 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 31,653 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 35,174 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 35,124 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥380.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥378.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥344.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥375.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥376.8bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥82.0bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥45.4bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥152.3bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥57.2bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥49.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥44.0bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥165.4bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥95.0bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥130.3bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥84.8bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥8.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥9.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥30.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥973.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥900.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥826.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥771.0bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥745.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥555.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥543.7bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥418.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥357.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥349.8bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥376.2bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥471.4bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥46m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥102.88 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.13 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.64 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.51 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.13 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥102.76 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥66.1 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥6.64 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥7.51 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.12 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥16 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥333.48 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥280.3 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥271.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥292.24 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥344.8 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 42.9% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.1% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 33.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.0% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,266,179,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,299,294,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,370,915,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,370,915,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 342,713,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,727 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 3,478 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 4,775 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 7,146 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 7,024 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 559 pure |
| Otherother segments | capex | 2022-04-01 → 2023-03-31 | ¥1.4bn |
| Otherother segments | segment assets | at 2023-03-31 | ¥20.6bn |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥914m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥11.7bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥479.2bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥28.9bn |
| Endoscopicreportable segment | employees | at 2023-03-31 | 14308 pure |
| Endoscopic Solutionsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥43.0bn |
| Endoscopic Solutionsreportable segment | segment assets | at 2023-03-31 | ¥555.5bn |
| Endoscopic Solutionsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥152.8bn |
| Scientific Solutionsreportable segment | employees | at 2023-03-31 | 4124 pure |
| Therapeuticreportable segment | employees | at 2023-03-31 | 8448 pure |
| Therapeutic Solutionsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥15.9bn |
| Therapeutic Solutionsreportable segment | segment assets | at 2023-03-31 | ¥453.0bn |
| Therapeutic Solutionsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥63.7bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥60.3bn |
| —segment total | segment assets | at 2023-03-31 | ¥1.03T |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥215.5bn |
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥997m |
| Otherother segments | segment assets | at 2022-03-31 | ¥20.9bn |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥2.0bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥8.4bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥430.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥45.8bn |
| Endoscopic Solutionsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥40.4bn |
| Endoscopic Solutionsreportable segment | segment assets | at 2022-03-31 | ¥493.6bn |
| Endoscopic Solutionsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥133.2bn |
| Therapeutic Solutionsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥16.3bn |
| Therapeutic Solutionsreportable segment | segment assets | at 2022-03-31 | ¥412.9bn |
| Therapeutic Solutionsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥60.8bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥57.8bn |
| —segment total | segment assets | at 2022-03-31 | ¥927.4bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥192.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 6 pure |
| Endoscopicreportable segment | employees | at 2023-03-31 | 566 pure |
| Therapeuticreportable segment | employees | at 2023-03-31 | 279 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,881
| Item | Context | Value | Unit |
|---|---|---|---|
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E02272-000TakedaChikashiMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000TakedaChikashiMember | Original text (Japanese)（注）1 | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000NachoAbiaMember | Original text (Japanese)執行役チーフストラテジーオフィサー（CSO） | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000NachoAbiaMember | Original text (Japanese)ナチョ・アビア | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000NachoAbiaMember | 1968-08-03 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E02272-000NachoAbiaMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000NachoAbiaMember | Original text (Japanese)（注）1 | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KobayashiTetsuoMember | Original text (Japanese)執行役チーフマニュファクチャリングアンドサプライオフィサー（CMSO） | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KobayashiTetsuoMember | Original text (Japanese)小林 哲男 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KobayashiTetsuoMember | 1960-06-17 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E02272-000KobayashiTetsuoMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KobayashiTetsuoMember | Original text (Japanese)（注）1 | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000AndreRogganMember | Original text (Japanese)執行役チーフテクノロジーオフィサー（CTO） | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000AndreRogganMember | Original text (Japanese)アンドレ・ローガン | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000AndreRogganMember | 1962-09-19 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E02272-000AndreRogganMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000AndreRogganMember | Original text (Japanese)（注）1 | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000OhtsukiShigetoMember | Original text (Japanese)執行役チーフヒューマンリソーシズオフィサー（CHRO） | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000OhtsukiShigetoMember | Original text (Japanese)大月 重人 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000OhtsukiShigetoMember | 1961-11-12 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E02272-000OhtsukiShigetoMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000OhtsukiShigetoMember | Original text (Japanese)（注）1 | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000PierreBoisierMember | Original text (Japanese)執行役チーフクオリティオフィサー（CQO） | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000PierreBoisierMember | Original text (Japanese)ピエール・ボワシエ | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000PierreBoisierMember | 1958-07-26 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E02272-000PierreBoisierMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000PierreBoisierMember | Original text (Japanese)（注）1 | |
| Footnotes executive officers (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes executive officers (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes executive officers (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)㈱オハラ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)ウシオ電機㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)有 | |
| Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)なお、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しています。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc and internal system to prepare consolidated financial statements etc fairly in accordance with IFRS financial information | CurrentYearDuration | Text · Plus | |
| Consolidated statement of financial position IFRS (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of profit or loss IFRS (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |